Abate Kristininsider trades

In SEC Form 4 filings, Abate Kristin is listed as Chief Accounting Officer of Karyopharm Therapeutics Inc. (KPTI). In the last 90 days, Abate Kristin sold $2.1K of Karyopharm Therapeutics Inc. (KPTI) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
KPTIKaryopharm Therapeutics Inc.	Chief Accounting Officer	3	Oct 19

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-02

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
KPTIKaryopharm Therapeutics Inc.	Oct 16	Oct 19	S	4,788	$0.34	Sale −$1,647	18,616	No	Form 4
KPTIKaryopharm Therapeutics Inc.	Oct 1	Oct 2	S	378	$1.19	Sale −$450	23,404	No	Form 4
KPTIKaryopharm Therapeutics Inc.	Sep 1	Sep 2	S	19	$2.02	Sale −$38	23,782	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.